Clinical Trial TitlePublic health surveillance for the prevention of complications of bleeding and clotting disorders.
Clinical Trial Protocol Description:
HIV and hepatitis C screening. Lab draws for testing inhibitors.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have hemophilia, von Willebrand disease, or another bleeding disorder.
- Have received blood based product via infusion/transfusion.
This is a partial list of elgibility requirements.